Factors that influence the immune response to vaccination

P Zimmermann, N Curtis - Clinical microbiology reviews, 2019 - Am Soc Microbiol
There is substantial variation between individuals in the immune response to vaccination. In
this review, we provide an overview of the plethora of studies that have investigated factors …

Vibrio spp. infections

C Baker-Austin, JD Oliver, M Alam, A Ali… - Nature Reviews …, 2018 - nature.com
Vibrio is a genus of ubiquitous bacteria found in a wide variety of aquatic and marine
habitats; of the> 100 described Vibrio spp.,~ 12 cause infections in humans. Vibrio cholerae …

Causes of impaired oral vaccine efficacy in developing countries

EPK Parker, S Ramani, BA Lopman, JA Church… - Future …, 2018 - Taylor & Francis
Oral vaccines are less immunogenic when given to infants in low-income compared with
high-income countries, limiting their potential public health impact. Here, we review factors …

Diagnosis, management, and future control of cholera

F Chowdhury, AG Ross, MT Islam… - Clinical Microbiology …, 2022 - Am Soc Microbiol
Cholera, caused by Vibrio cholerae, persists in developing countries due to inadequate
access to safe water, sanitation, and hygiene. There are approximately 4 million cases and …

Efficacy and safety of a modified killed-whole-cell oral cholera vaccine in India: an interim analysis of a cluster-randomised, double-blind, placebo-controlled trial

D Sur, AL Lopez, S Kanungo, A Paisley, B Manna… - The Lancet, 2009 - thelancet.com
Background Oral cholera vaccines consisting of killed whole cells have been available for
many years, but they have not been used extensively in populations with endemic disease …

[HTML][HTML] Current and future cholera vaccines

H Shaikh, J Lynch, J Kim, JL Excler - Vaccine, 2020 - Elsevier
Cholera remains a major global public health problem that is primarily linked to insufficient
access to safe water and proper sanitation. Oral Cholera Vaccine (OCV) has been …

[HTML][HTML] Cholera in India: an analysis of reports, 1997-2006

S Kanungo, BK Sah, AL Lopez… - Bulletin of the World …, 2010 - SciELO Public Health
OBJECTIVE: To more accurately define the annual incidence of cholera in India, believed to
be higher than reported to the World Health Organization (WHO). METHODS: We searched …

[HTML][HTML] Global oral cholera vaccine use, 2013–2018

L Pezzoli - Vaccine, 2020 - Elsevier
Vaccination is a key intervention to prevent and control cholera in conjunction with water,
sanitation and hygiene activities. An oral cholera vaccine (OCV) stockpile was established …

[HTML][HTML] The Euvichol story–Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships

L Odevall, D Hong, L Digilio, S Sahastrabuddhe… - Vaccine, 2018 - Elsevier
Cholera, a diarrheal disease primarily affecting vulnerable populations in developing
countries, is estimated to cause disease in more than 2.5 million people and kill almost …

Safety and immunogenicity study of a killed bivalent (O1 and O139) whole-cell oral cholera vaccine Shanchol, in Bangladeshi adults and children as young as 1 year …

A Saha, MI Chowdhury, F Khanam, MS Bhuiyan… - Vaccine, 2011 - Elsevier
BACKGROUND: Safety and immunogenicity study of an oral, killed, bivalent whole-cell,
cholera vaccine, Shanchol was carried out in Bangladeshi participants. This study was …